Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of 25.23 million. The enterprise value is 39.34 million.
| Market Cap | 25.23M |
| Enterprise Value | 39.34M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 76.75M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +292.49% |
| Shares Change (QoQ) | +4.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 42.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.79 |
| PB Ratio | -1.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.44 |
| EV / Sales | 5.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.50 |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.90 |
| Interest Coverage | -1.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 650.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +733.03% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +733.03% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 53.26 |
| Average Volume (20 Days) | 11,907 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of 6.66 million and -27.33 million in losses. Loss per share was -1.13.
| Revenue | 6.66M |
| Gross Profit | 5.02M |
| Operating Income | -14.09M |
| Pretax Income | -27.33M |
| Net Income | -27.33M |
| EBITDA | -13.76M |
| EBIT | -14.09M |
| Loss Per Share | -1.13 |
Balance Sheet
The company has 720,771 in cash and 14.16 million in debt, giving a net cash position of -13.44 million.
| Cash & Cash Equivalents | 720,771 |
| Total Debt | 14.16M |
| Net Cash | -13.44M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -18.76M |
| Book Value Per Share | -0.42 |
| Working Capital | -5.29M |
Cash Flow
In the last 12 months, operating cash flow was -15.51 million and capital expenditures -224,719, giving a free cash flow of -15.74 million.
| Operating Cash Flow | -15.51M |
| Capital Expenditures | -224,719 |
| Free Cash Flow | -15.74M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 75.30% |
| Operating Margin | -211.57% |
| Pretax Margin | -410.24% |
| Profit Margin | n/a |
| EBITDA Margin | -206.52% |
| EBIT Margin | -211.57% |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -292.49% |
| Shareholder Yield | n/a |
| Earnings Yield | -108.30% |
| FCF Yield | -62.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Conavi Medical has an Altman Z-Score of -41.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -41.3 |
| Piotroski F-Score | 3 |